A Phase I Study of MK-0752, a Notch Inhibitor, in Patients with Metastatic or Locally Advanced Breast Cancer and Other Solid Tumors (Merck Protocol No. 014-07).
Phase of Trial: Phase I
Latest Information Update: 09 Apr 2010
At a glance
- Drugs MK 0752 (Primary)
- Indications Advanced breast cancer; Solid tumours
- Focus Adverse reactions
- 09 Apr 2010 New trial record